Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 9/2019

01-09-2019 | Rituximab | Letter to the Editor

Outcomes of autologous stem cell transplantation in Waldenström’s macroglobulinemia

Authors: Neeraj Y. Saini, Romil D Patel, Ankur Varma, Qaiser Bashir, Ruby Delgado, Gabriela Rondon, Akash Mukherjee, Uday Popat, Chitra Hosing, Yago Nieto, Partow Kebriaei, Donna M. Weber, Sheeba K. Thomas, Hans C. Lee, Elisabet E. Manasanch, Robert Z. Orlowski, Richard E. Champlin, Muzaffar H. Qazilbash, Krina K. Patel

Published in: Annals of Hematology | Issue 9/2019

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Sekhar J, Sanfilippo K, Zhang Q, Trinkaus K, Vij R, Morgensztern D (2012) Waldenström macroglobulinemia: a surveillance, epidemiology, and end results database review from 1988 to 2005. Leuk Lymphoma 53:1625–1626CrossRefPubMed
2.
Treon SP, Tripsas CK, Meid K, Warren D, Varma G, Green R, Argyropoulos KV, Yang G, Cao Y, Xu L, Patterson CJ, Rodig S, Zehnder JL, Aster JC, Harris NL, Kanan S, Ghobrial I, Castillo JJ, Laubach JP, Hunter ZR, Salman Z, Li J, Cheng M, Clow F, Graef T, Palomba ML, Advani RH (2015) Ibrutinib in previously treated Waldenström’s macroglobulinemia. N Engl J Med 372:1430–1440CrossRefPubMed
3.
Dimopoulos MA, Tedeschi A, Trotman J, García-Sanz R, Macdonald D, Leblond V, Mahe B, Herbaux C, Tam C, Orsucci L, Palomba ML, Matous JV, Shustik C, Kastritis E, Treon SP, Li J, Salman Z, Graef T, Buske C, iNNOVATE Study Group and the European Consortium for Waldenström’s Macroglobulinemia (2018) Phase 3 trial of ibrutinib plus rituximab in Waldenström’s macroglobulinemia. N Engl J Med 378:2399–2410CrossRefPubMed
4.
5.
Morel P, Duhamel A, Gobbi P, Dimopoulos MA, Dhodapkar MV, McCoy J, Crowley J, Ocio EM, Garcia-Sanz R, Treon SP, Leblond V, Kyle RA, Barlogie B, Merlini G (2009) International prognostic scoring system for Waldenstrom macroglobulinemia. Blood 113:4163–4170CrossRefPubMed
6.
Kyriakou C, Canals C, Sibon D, Cahn JY, Kazmi M, Arcese W, Kolbe K, Gorin NC, Thomson K, Milpied N, Niederwieser D, Indrák K, Corradini P, Sureda A, Schmitz N (2010) High-dose therapy and autologous stem-cell transplantation in Waldenstrom macroglobulinemia: the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 28:2227–2232CrossRefPubMed
7.
Marzolini MAV, Thomson KJ, Dorman J, D’Sa S (2014) BEAM-conditioned autologous SCT improves the quality of response in Waldenström’s macroglobulinaemia and lymphoplasmacytic lymphoma: a single centre’s 10-year experience. Bone Marrow Transplant 49:1231–1232CrossRefPubMed
8.
Caravita T, Siniscalchi A, Tendas A, Cupelli L, Dentamaro T, Natale G, Spagnoli A, de Fabritiis P (2009) High-dose therapy with autologous PBSC transplantation in the front-line treatment of Waldenstrom’s macroglobulinemia. Bone Marrow Transplant 43:587–588CrossRefPubMed
9.
Baron M, Simon L, Poulain S, Leblond V (2019) How recent advances in biology of Waldenström’s macroglobulinemia may affect therapy strategy. Curr Oncol Rep 21:27CrossRefPubMed
Metadata
Title
Outcomes of autologous stem cell transplantation in Waldenström’s macroglobulinemia
Authors
Neeraj Y. Saini
Romil D Patel
Ankur Varma
Qaiser Bashir
Ruby Delgado
Gabriela Rondon
Akash Mukherjee
Uday Popat
Chitra Hosing
Yago Nieto
Partow Kebriaei
Donna M. Weber
Sheeba K. Thomas
Hans C. Lee
Elisabet E. Manasanch
Robert Z. Orlowski
Richard E. Champlin
Muzaffar H. Qazilbash
Krina K. Patel
Publication date
01-09-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 9/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-019-03734-7

Other articles of this Issue 9/2019

Annals of Hematology 9/2019 Go to the issue

Letter to the Editor

Blastic plasmacytoid dendritic cell neoplasm with unusual lymphoid features and macrovacuoles

Original Article

BOK promotes erythropoiesis in a mouse model of myelodysplastic syndrome

Letter to the Editor

Successful treatment of nasal-type extra-nodal natural killer/T cell lymphoma with simultaneous involvement of the thyroid, liver, and pancreas

Original Article

Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II study

Review Article

Pixantrone beyond monotherapy: a review

Original Article

Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits